PURPOSE OF REVIEW: Bleeding and death from hemorrhage remain a leading cause of morbidity and mortality in the trauma population. Early resuscitation of these gravely injured patients has changed significantly over the past several years. The concept of damage control resuscitation has expanded significantly with the experience of the US military in southwest Asia. This review will focus on this resuscitation strategy of transfusing blood products (red cells, plasma, and platelets) early and often in the exsanguinating patient. RECENT FINDINGS: In trauma there are no randomized controlled trials comparing the current damage control hematology concept to more traditional resuscitation methods. But the overwhelming conclusion of the data available support the administration of a high ratio of plasma and platelets to packed red blood cells. Several large retrospective studies have shown ratios close to 1: 1 will result in higher survival. SUMMARY: The current evidence supports that the acute coagulopathy of trauma is present in a high percentage of trauma patients. Patients who will require a massive transfusion will have improved outcomes the earlier that this is identified and the earlier that damage control hematology is instituted. Current evidence does not describe the best ratio but the preponderance of the data suggests it should be greater than 2: 3 plasma-to-packed red blood cells.
PURPOSE OF REVIEW: Bleeding and death from hemorrhage remain a leading cause of morbidity and mortality in the trauma population. Early resuscitation of these gravely injured patients has changed significantly over the past several years. The concept of damage control resuscitation has expanded significantly with the experience of the US military in southwest Asia. This review will focus on this resuscitation strategy of transfusing blood products (red cells, plasma, and platelets) early and often in the exsanguinating patient. RECENT FINDINGS: In trauma there are no randomized controlled trials comparing the current damage control hematology concept to more traditional resuscitation methods. But the overwhelming conclusion of the data available support the administration of a high ratio of plasma and platelets to packed red blood cells. Several large retrospective studies have shown ratios close to 1: 1 will result in higher survival. SUMMARY: The current evidence supports that the acute coagulopathy of trauma is present in a high percentage of traumapatients. Patients who will require a massive transfusion will have improved outcomes the earlier that this is identified and the earlier that damage control hematology is instituted. Current evidence does not describe the best ratio but the preponderance of the data suggests it should be greater than 2: 3 plasma-to-packed red blood cells.
Authors: Philip C Spinella; Jeremy G Perkins; Daniel F McLaughlin; Sarah E Niles; Kurt W Grathwohl; Alec C Beekley; Jose Salinas; Sumeru Mehta; Charles E Wade; John B Holcomb Journal: J Trauma Date: 2008-02
Authors: D F O'Shaughnessy; C Atterbury; P Bolton Maggs; M Murphy; D Thomas; S Yates; L M Williamson Journal: Br J Haematol Date: 2004-07 Impact factor: 6.998
Authors: Matthew A Borgman; Philip C Spinella; Jeremy G Perkins; Kurt W Grathwohl; Thomas Repine; Alec C Beekley; James Sebesta; Donald Jenkins; Charles E Wade; John B Holcomb Journal: J Trauma Date: 2007-10
Authors: Martin A Schreiber; Jeremy Perkins; Laszlo Kiraly; Samantha Underwood; Charles Wade; John B Holcomb Journal: J Am Coll Surg Date: 2007-08-08 Impact factor: 6.113
Authors: Demetrios Demetriades; James Murray; Kiriakos Charalambides; Kathy Alo; George Velmahos; Peter Rhee; Linda Chan Journal: J Am Coll Surg Date: 2004-01 Impact factor: 6.113
Authors: Michael Kuncewitch; Weng-Lang Yang; Asha Jacob; Adam Khader; Matthew Giangola; Jeffrey Nicastro; Gene F Coppa; Ping Wang Journal: J Trauma Acute Care Surg Date: 2015-04 Impact factor: 3.313
Authors: Andrew J Shoffstall; Kristyn T Atkins; Rebecca E Groynom; Matthew E Varley; Lydia M Everhart; Margaret M Lashof-Sullivan; Blaine Martyn-Dow; Robert S Butler; Jeffrey S Ustin; Erin B Lavik Journal: Biomacromolecules Date: 2012-10-08 Impact factor: 6.988
Authors: Jill L Sondeen; Malcolm D Prince; Irene A Polykratis; Orlando Hernandez; Jaime Torres-Mendoza; Rodolfo De Guzman; James K Aden; Michael A Dubick Journal: J Am Assoc Lab Anim Sci Date: 2014-05 Impact factor: 1.232
Authors: Andrew J Shoffstall; Lydia M Everhart; Matthew E Varley; Eric S Soehnlen; Adam M Shick; Jeffrey S Ustin; Erin B Lavik Journal: Biomacromolecules Date: 2013-07-24 Impact factor: 6.988
Authors: D Thomas; M Wee; P Clyburn; I Walker; K Brohi; P Collins; H Doughty; J Isaac; P M Mahoney; L Shewry Journal: Anaesthesia Date: 2010-11 Impact factor: 6.955